首页> 外国专利> Heparin binding--epidermal growth factor-like growth factor in the diagnosis of Interstitial Cystitis

Heparin binding--epidermal growth factor-like growth factor in the diagnosis of Interstitial Cystitis

机译:肝素结合-表皮生长因子样生长因子在间质性膀胱炎的诊断中

摘要

Interstitial cystitis (IC) is a chronic bladder disease for which the exact etiology is unknown and for which there is no reliably effective treatment. However, it is known that the bladder epithelium is often abnormal in IC. We discovered that normal, adult, human bladder epithelial cells are inhibited from proliferating by an anti- proliferative fact (APF) present in IC urine specimens. Inhibited proliferation may cause epthelial abnormalities characteristic of IC such as ulcerations and multiple tears in the bladder epithelium. We further discovered that levels of heparin binding--epidermal growth factor-like growth fact (HB-EGF), a factor known be important for epithelial cell proliferation and wound healing in other tissues, are abnormally low in the urine of patients suffering from IC as compared to asymptomatic controls or patients with acute bacterial cystitis. The invention herein is directed to the use of urine levels of HB-EGF as a diagnostic marker for IC.
机译:间质性膀胱炎(IC)是一种慢性膀胱疾病,其确切病因尚不清楚,并且没有可靠的有效治疗方法。然而,已知膀胱上皮在IC中通常是异常的。我们发现正常的,成年的人膀胱上皮细胞受到IC尿液样本中存在的抗增殖因子(APF)的抑制。抑制的增殖可能会引起IC的上皮异常,例如溃疡和膀胱上皮多裂。我们进一步发现肝素结合-表皮生长因子样生长因子(HB-EGF)的水平在患有IC的患者的尿中异常低,这是已知对其他组织的上皮细胞增殖和伤口愈合很重要的因子与无症状对照组或急性细菌性膀胱炎患者相比。本文中的本发明涉及HB-EGF的尿水平作为IC的诊断标志物的用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号